Keywords: حجم انبساط اجباری در 1 ثانیه; BHR; Bronchial responsiveness to metacholine; COPD; Chronic obstructive pulmonary disease; ECRHS; European Community Respiratory Health Survey; FEV1; Forced expiratory volume in 1â¯s; FVC; Forced vital capacity; LLN; Lower limit of normal; GAMMs; General
مقالات ISI حجم انبساط اجباری در 1 ثانیه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حجم انبساط اجباری در 1 ثانیه; Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
Keywords: حجم انبساط اجباری در 1 ثانیه; CI; confidence interval; COPD; chronic obstructive pulmonary disease; DBP; dibutyl phthalate; DEHP; di-(2-ethylhexyl) phthalate; FEF25-75; forced expiratory flow at 25-75% of the forced vital capacity; FEV1; forced expiratory volume in 1â¯s; FEV1/FVC
Keywords: حجم انبساط اجباری در 1 ثانیه; TRAP; Traffic Related Air Pollution; TAHS; Tasmanian Longitudinal Health Study; RHINE; Respiratory Health in Northern Europe; ECRHS; European Community Respiratory Health Survey; ESCAPE; European Study of Cohorts for Air Pollution Effects; PM10; particula
Keywords: حجم انبساط اجباری در 1 ثانیه; Bronchodilator agents; Electrocardiography; GFF MDI; Pulmonary disease; Chronic obstructive; Holter monitoring; QT prolongation; AE; adverse event; AV; atrioventricular; BID; twice daily; BMI; body mass index; bpm; beats per minute; CI; confidence interva
Keywords: حجم انبساط اجباری در 1 ثانیه; AAF; average attributable fraction; BMI; body mass index; CV; cardiovascular; FEV1; forced expiratory volume in 1â¯s; FVC; forced vital capacity; GLI; Global Lung Function Initiative; HR; hazard ratio; nonCV; noncardiovascular; RR; rate ratio;
Keywords: حجم انبساط اجباری در 1 ثانیه; CF; cystic fibrosis; CPET; cardiopulmonary exercise test; FEV1; forced expiratory volume in 1â¯s; HR; heart rate; SpO2; oxygen saturations measured by pulse oximetry; VÌO2; oxygen uptake; VÌCO2; carbon dioxide elimination; VÌE; minute ventilation; VD;
Keywords: حجم انبساط اجباری در 1 ثانیه; 25(OH)D; 25-hydroxyvitamin D; BMD; bone mineral density; BMI; body mass index; CF; cystic fibrosis; DXA; dual energy Xray absorptiometry; FEV1; forced expiratory volume in 1â¯s; GVHD; graft versus host disease; PTH; parathyroid hormone; TBLH; total body
Keywords: حجم انبساط اجباری در 1 ثانیه; TRAP; tracheal anterior, posterior (AP) diameter; TRT; tracheal transverse diameter; AEAP; azygoesophageal AP diameter; AET; azygoesophageal transverse diameter; TV; thoracic vertical diameter; TAP; thoracic AP diameter; TT; thoracic transverse diameter;
Keywords: حجم انبساط اجباری در 1 ثانیه; Chinese herbal medicine formula; Acute asthma; Randomized controlled trial; Inflammatory cytokines; Proof-of-concept; ASHMI; antiasthma simplified herbal medicine intervention; CRP; C-reactive protein; ELISA; enzyme - linked immunosorbent assay; ERS; Euro
Keywords: حجم انبساط اجباری در 1 ثانیه; Time-to-treatment; Disease-free survival; Overall survival; Lung cancer; Curative intent treatment; ACCP; American College of Chest Physicians; BTS; British Thoracic Society; CAD; coronary artery disease; CI; confidence interval; COPD; chronic obstructive
Keywords: حجم انبساط اجباری در 1 ثانیه; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
Keywords: حجم انبساط اجباری در 1 ثانیه; Co-suspension delivery technology; Formoterol fumarate dihydrate; Glycopyrronium; Metered dose inhaler; Spacer; Valved holding chamber; AE; adverse event; ANOVA; analysis of variance; AUC0-12; area under the curve from 0 to 12â¯h; BMI; body mass index;
Early life growth patterns persist for 12â¯years and impact pulmonary outcomes in cystic fibrosis
Keywords: حجم انبساط اجباری در 1 ثانیه; BMIz; age- and sex-specific z-scores for body mass index; CF; cystic fibrosis; CXR; chest radiograph; FEV1; forced expiratory volume in 1â¯s; HTz; age- and sex-specific z-scores for length (<2â¯years) or height (â¥2â¯years); I6; non-responders whose g
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Keywords: حجم انبساط اجباری در 1 ثانیه; Tiotropium; Long-acting muscarinic antagonist; Long-acting β2-agonist; Inhaled corticosteroids; Asthma; ACRN; Asthma Clinical Research Network; AE; adverse event; B16-Arg/Arg; arginine single nucleotide polymorphism at amino acid 16 in the β2-adrenergic
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5â¯years of treatment
Keywords: حجم انبساط اجباری در 1 ثانیه; Morquio A; Mucopolysaccharidosis IVA; Long-term extension; Elosulfase alfa; 3MSCT; 3-min stair climb test; 6MWT; 6-min walk test; AE; adverse event; AUC0ât; area under the curve from time 0 to last measurable concentration; AUCinf; area under the curve
Residential air pollution does not modify the positive association between physical activity and lung function in current smokers in the ECRHS study
Keywords: حجم انبساط اجباری در 1 ثانیه; ALEC; Ageing Lungs in European Cohorts; BMI; body mass index; COPD; chronic obstructive pulmonary disease; ECRHS; European Community Respiratory Health Survey; ESCAPE; European Study of Cohorts for Air Pollution Effects; FEV1; forced expiratory volume in
Studying allergic inflammation and spirometry over menstrual cycles in well-controlled asthmatic women: Changes in progesterone and estradiol affect neither FENO levels nor lung function
Keywords: حجم انبساط اجباری در 1 ثانیه; Fractioned exhaled nitric oxide (FENO); Asthma monitoring; Female sex hormones; Menstrual cycle; Progesterone in asthma; Women asthma; Pg; progesterone; E; estradiol; ACT; asthma control test; FENO; fractioned exhaled nitric oxide; ER; estrogen receptors;
Impact of doxofylline in COPD: A pairwise meta-analysis
Keywords: حجم انبساط اجباری در 1 ثانیه; Doxofylline; Chronic obstructive pulmonary disease; Lung function; Safety; Pairwise meta-analysis; AE; adverse events; CI; confidence interval; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1â¯s; GRADE; Grading of Recomme
NOD2 expression, DNA damage and oxido-inflammatory status in atopic bronchial asthma: Exploring their nexus to disease severity
Keywords: حجم انبساط اجباری در 1 ثانیه; 3-NT; 3-nitrotyrosine; CHIT1; Chitotriosidase enzyme; FEV1; Forced expiratory volume in 1â¯s; FVC; forced vital capacity; GST; Glutathione-S-transferase; MDA; Malondialdehyde; NLR; Nod-like receptor; Nod2; nucleotide-binding oligomerization domain 2; PAM